Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovaBay Pharmaceuticals

0.6101
0.0000
Volume:7.35K
Turnover:4.48K
Market Cap:3.55M
PE:1.08
High:0.6192
Open:0.6000
Low:0.6000
Close:0.6101
Loading ...
Jul 23, 2024

Correspondence

Form CORRESP - Correspondence
Jul 23, 2024

Correspondence

Form CORRESP - Correspondence
Jul 13, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 11, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 11, 2024

Major Issues Report

Form 8-K - Current report
Jul 10, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 10, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 26, 2024

Correspondence

Form CORRESP - Correspondence
Jun 21, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 21, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 20, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 22, 2024

Major Issues Report

Form 8-K - Current report
Apr 19, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]